# clm_1EFA1709BF1A

subject: Eli Lilly and Company (/record/eli-lilly.md)  
predicate: cash_and_equivalents  
value: 3,786,500,000 United States dollar  
valid_from: 2013-06-30  
valid_to: 2013-09-30  
published: 2013-07-26  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_AA58254D76F9  
last_updated: 2026-11-08  
cite: AsOf. "Eli Lilly and Company cash and equivalents: 3,786,500,000 United States dollar", as of 2013-06-30 (until 2013-09-30). Claim clm_1EFA1709BF1A, https://asof.is/claim/clm_1EFA1709BF1A, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947813000043/0000059478-13-000043-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-07-26  

## Sources

- https://www.sec.gov/Archives/edgar/data/59478/000005947813000043/0000059478-13-000043-index.htm (primary, SEC EDGAR 10-Q Q2 FY2013, published 2013-07-26)

## Supersedes

- [Eli Lilly and Company](/record/eli-lilly.md) | cash_and_equivalents | 3,936,600,000 United States dollar | valid 2013-03-31 to 2013-06-30 | conf 0.95 | superseded | superseded_by [clm_1EFA1709BF1A](/claim/clm_1EFA1709BF1A.md) | [clm_1F2201F2D0BD](/claim/clm_1F2201F2D0BD.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.